1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa miRNA Sequencing and Assay Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa miRNA Sequencing and Assay Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa miRNA Sequencing and Assay Market Regional Analysis
6.2 Middle East and Africa miRNA Sequencing and Assay Market Revenue 2017-2027 (US$ Million)
6.3 Middle East and Africa miRNA Sequencing and Assay Market Forecast Analysis
7. Middle East and Africa miRNA Sequencing and Assay Market Analysis – by Product
7.1 Library Preparation
- 7.1.1 Overview
- 7.1.2 Library Preparation: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Consumables
- 7.2.1 Overview
- 7.2.2 Consumables: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Middle East and Africa miRNA Sequencing and Assay Market Analysis – by Technology
8.1 Sequencing Synthesis
- 8.1.1 Overview
- 8.1.2 Sequencing Synthesis: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Nanopore
- 8.2.1 Overview
- 8.2.2 Nanopore: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Ion Semiconductor Sequencing
- 8.3.1 Overview
- 8.3.2 Ion Semiconductor Sequencing: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Middle East and Africa miRNA Sequencing and Assay Market Analysis – by End User
9.1 Research Institute
- 9.1.1 Overview
- 9.1.2 Research Institute: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Academia
- 9.2.1 Overview
- 9.2.2 Academia: Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 CRO
- 9.3.1 Overview
- 9.3.2 CRO : Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Middle East and Africa miRNA Sequencing and Assay Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa
- 10.2.1 Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 Middle East and Africa miRNA Sequencing and Assay Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 South Africa:
Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Product
- 10.2.1.1.2 South Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Technology
- 10.2.1.1.3 South Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by End User
- 10.2.1.2 Saudi Arabia:
Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Product
- 10.2.1.2.2 Saudi Arabia: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Technology
- 10.2.1.2.3 Saudi Arabia: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by End User
- 10.2.1.3 UAE:
Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 UAE: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Product
- 10.2.1.3.2 UAE: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Technology
- 10.2.1.3.3 UAE: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by End User
- 10.2.1.4 Rest of Middle East and Africa:
Middle East and Africa miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Product
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by Technology
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa miRNA Sequencing and Assay Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Illumina, Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 QIAGEN
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Perkin Elmer, Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Takara Bio Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 New England Biolabs
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Norgen Biotek Corp
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 TriLink BioTechnologies Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Lexogen GmbH
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Oxford Nanopore Technologies
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations